In the BioHarmony Drug Report Database

"Preview" Icon

Gadobutrol

Gadavist (gadobutrol) is a small molecule pharmaceutical. Gadobutrol was first approved as Gadavist on 2011-03-14. Gadavist’s patent is valid until 2021-11-09 (FDA).

 

Trade Name

 

Gadavist
 

Common Name

 

gadobutrol
 

ChEMBL ID

 

CHEMBL2218860
 

Indication

 

 

Drug Class

 

Gadolinium derivatives (principally for diagnostic use)

Image (chem structure or protein)

Gadobutrol structure rendering